Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Cash & Equivalents (2016 - 2026)

Natural Health Trends (NHTC) has disclosed Cash & Equivalents for 17 consecutive years, with $4.8 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 77.85% year-over-year to $4.8 million; the TTM value through Mar 2026 reached $4.8 million, down 77.85%, while the annual FY2025 figure was $5.9 million, 56.54% down from the prior year.
  • Cash & Equivalents hit $4.8 million in Q1 2026 for Natural Health Trends, down from $5.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $79.5 million in Q1 2022 and bottomed at $4.8 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $39.2 million, with a median of $25.9 million recorded in 2024.
  • Year-over-year, Cash & Equivalents fell 12.42% in 2022 and then tumbled 77.85% in 2026.
  • Natural Health Trends' Cash & Equivalents stood at $69.7 million in 2022, then fell by 19.4% to $56.2 million in 2023, then crashed by 75.87% to $13.6 million in 2024, then plummeted by 56.54% to $5.9 million in 2025, then decreased by 18.4% to $4.8 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $4.8 million, $5.9 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.